Literature DB >> 14534694

Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.

Lian-Xin Liu1, Hong-Chi Jiang, Zhi-Hua Liu, An-Long Zhu, Wei-Hui Zhang, Lin-Feng Wu, Jing Zhou, Xiu-Qin Wang, Min Wu.   

Abstract

We investigated the gene expression of the cell cycle/growth regulators in hepatocellular carcinoma (HCC) through the usage of Atlas human cancer array membranes, semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) and Northern blot. Hybridization of cDNA array membrane was performed with alpha-32P-labeled cDNA probes synthesized from RNA, isolated from HCC and adjacent non-cirrhotic normal liver. RT-PCR of 24 paired specimens and Northern blot of 4 paired specimens were used to confirm the expression patterns of the cell cycle/growth regulator genes identified by Atlas array hybridization. Among 79 genes related to cell cycle/growth regulators, transcription factor DP2 (TFDP-2) and E2F-3 were up-regulated, whereas dual-specificity mitogen-activated protein kinase kinase 1 (MAPKK1) and cell division protein kinase 3 (CDK3) were down-regulated in HCC. RT-PCR of TFDP-2 gave result consistent with Atlas human cancer cDNA array findings. Northern blot analysis of TFDP-2 and E2F-3 of 4 paired specimens all showed up-regulation in HCC compared to normal liver tissues. The results obtained from Atlas microarray provided for the first time a liver cancer-specific expression profile, which identified the gene expressions comprehensively and systematically. The findings may lead to better understanding of the mechanism of onset and progression of HCC. The rapid and high-throughout method of profiling gene expression by cDNA array provides an overview of the key factors that may be involved in HCC. Some genes are reported for the first time in HCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534694

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

Review 1.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Athanasios Xanthoulis; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

2.  Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.

Authors:  Yunhai Li; Jing Huang; Dejuan Yang; Shili Xiang; Jiazheng Sun; Hongzhong Li; Guosheng Ren
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

3.  Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.

Authors:  Yan-Lin Huang; Gang Ning; Lu-Biao Chen; Yi-Fan Lian; Yu-Rong Gu; Jia-Liang Wang; Dong-Mei Chen; Huan Wei; Yue-Hua Huang
Journal:  Cancer Manag Res       Date:  2019-02-19       Impact factor: 3.989

4.  Reconstructing dynamic gene regulatory networks from sample-based transcriptional data.

Authors:  Hailong Zhu; R Shyama Prasad Rao; Tao Zeng; Luonan Chen
Journal:  Nucleic Acids Res       Date:  2012-09-21       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.